VFA
MACK

Voya Financial Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Voya Financial Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,400
Closed -$85K – 660
2021
Q1 		$85K Buy
+13,400
New +$95.8K ﹤0.01% 654

Other funds holding MACK

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Voya Financial Advisors's MACK Position: Q2 2021 in Review

Voya Financial Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2021, closing a stake of 13,400 shares — an estimated $85K sold.

Voya Financial Advisors first reported a position in MACK in Q1 2021 and held it in 1 quarter. The position peaked at $85K in Q1 2021. 43 funds tracked by Wall St. Rank hold MACK as of Q2 2021.

  • Voya Financial Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 13,400 Merrimack Pharmaceuticals, Inc. shares in Q2 2021, an estimated $85K.
  • Voya Financial Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
  • Voya Financial Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $85K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.